{"issuance_frequency":"","notes_translated":{"fr":"Le Programme d'accès spécial (PAS) permet aux médecins qui traitent des patients atteints de maladies graves ou mortelles d'accéder à des médicaments non disponibles sur le marché, lorsque les thérapies habituelles se sont révélées inefficaces, ne conviennent pas ou ne sont pas disponibles. Le PAS autorise un fabricant à vendre un médicament qui ne peut autrement être vendu ou distribué au Canada. ","en":"The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"49221b57-1fe5-488f-943b-886e73c8dbd2","metadata_created":"2020-09-17T20:11:07.915374","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T20:11:07.915379","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Accès spécial aux médicaments et aux produits de santé","Programme d'accès spécial","accès à des médicaments non disponibles sur le marché"],"en":["Special Access to Drugs and Health Products","Special Access Programme","access to nonmarketed drugs."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Médicaments - Accès spécial aux médicaments et aux produits de santé","en":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"49221b57-1fe5-488f-943b-886e73c8dbd2","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"41c42492-8a75-44e1-9bbe-2d609c6861ef","related_relationship":"","name_translated":{"fr":"Médicaments - Accès spécial aux médicaments et aux produits de santé","en":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products","language":["en"],"created":"2020-09-17T20:11:08.059072","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs.html","last_modified":null,"position":0,"revision_id":"6e5f892d-e089-4a93-887a-bfb5f031937a","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"49221b57-1fe5-488f-943b-886e73c8dbd2","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f227357a-eab0-4dc1-b01f-21e1cae14ef1","related_relationship":"","name_translated":{"fr":"Médicaments - Accès spécial aux médicaments et aux produits de santé","en":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products","language":["fr"],"created":"2020-09-17T20:11:08.059079","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/acces-special/medicaments.html","last_modified":null,"position":1,"revision_id":"6e5f892d-e089-4a93-887a-bfb5f031937a","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2018-07-05 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"49221b57-1fe5-488f-943b-886e73c8dbd2","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products","revision_id":"6e5f892d-e089-4a93-887a-bfb5f031937a"}